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Aims  
Ageing is irrevocably related to the degeneration of tissue and organs. Diseases 
and accidents often result in tissue or organ malfunction. Their replacement by 
artificial implants, donor tissue, or organs, holds very important restrictions. A new, 
more advanced biological approach seems to be the only long-term solution. An 
important contribution to this approach can be given by tissue engineering (TE). 
Bone TE specifically, topic of this study, is a multidisciplinary field of science focusing 
on healing large bone defects [1].  
One of the most promising bone TE approaches is the use of stem cells in 
combination with biomaterials (= scaffolds) and signalling molecules in order to 
create a 3D environment for bone tissue formation. For the evaluation of the bone 
forming capacity of specific stem cell – biomaterial combinations, both in vitro 
biomaterial screening/selection and in vivo assessment are required. In general, for 
the evaluation of in vivo experiments, the implanted cell-scaffold combination 
together with the newly formed tissue are explanted after a defined period and 
investigated by histomorphometry to identify and quantify the newly formed tissue [2-
5]. However, this procedure is destructive, time consuming, labour intensive, and 
provides only discrete 2D information. The latter is intrinsically related to the use of 
consecutive 2D histological sections with a significant interspace. Therefore, the 
quantification of the newly formed bone volume lacks information and cannot be 
referred to as real 3D information.  
As frequently reported in literature, microfocus X-ray computed tomography 
(micro-CT) shows a potential for partial replacement of, or complementary use with 
histomorphometry for the visualization and/or quantification of the newly formed bone 
tissue in and around bone TE scaffolds [6-13]. Additionally, the scaffold 
characteristics prior to implantation and after explantation can be quantified.  
In this study, for combinations of human periosteal derived cells (hPDCs) with 
clinical calcium phosphate (CaP) scaffolds, micro-CT was used for in-depth and 3D 
initial material and explant characterisation. Based on this information, a correlation 
between specific material properties and the in vivo bone formation has been 
developed. 
Materials and methods 
Five different commercially available orthopaedic 3D matrices composed of calcium 
phosphate (CaP) particles in an open collagen network (NuOss™, CopiOs™, Bio-
Oss®, Collagraft™ and Vitoss®) were selected. Each scaffold was scanned using 
high-resolution micro-CT on a Skyscan 1172 system [Skyscan NV, Kontich, Belgium] 
at an isotropic voxel size  of (4.5 µm)³. Since each biomaterial had a similar 
composition, for all materials a source voltage and current of 60kV and 167 µA 
respectively and a filter of 0.5mm Al were applied. Using a rotation step of 0.3° over a 
total of 180° resulted in 640 radiographic images. After reconstruction using 
dedicated software [NRecon, Skyscan NV, Kontich, Belgium], a total of about 900 
greyscale axial micro-CT images per sample were generated.  Manual, but 
consistent global segmentation of the CaP within each implant was carried out based 
on the greyscale histogram to allow quantification of parameters such as average 
grain size, surface area, volume fraction and specific surface area using CTAn 
[Skyscan NV, Kontich, Belgium]. 
One million hPDCs (in suspension) were applied to the upper surface of each 
scaffold. To allow cell attachment, the seeded scaffolds were incubated overnight at 
37°C. After incubation, the constructs were directly implanted subcutaneously in the 
back at the cervical region of NMRI-nu/nu mice. After 8 weeks of implantation, the 
implants were collected. Each explant was fixed in 4% formaldehyde, scanned by 
high-resolution micro-CT, decalcified in EDTA/PBS for 2 weeks, paraffin embedded 
and processed for histology. Fluorescence histomorphometry, as described by Martin 
et al. [14], was performed on tissue sections from each implant. Micro-CT image 
analysis was used to quantify the volume of newly formed bone in three dimensions 
by segmenting the newly formed mineralised tissues from the CaP grains in each 
material. Additionally, the bone interconnectivity was assessed, together with a 
spatial localisation of the bone formed within the scaffold structure. The same 
acquisition parameters as for the implanted biomaterials were used. For 
segmentation, again a manually selected, but consistent global threshold value was 
selected for each biomaterial. This time, the choice of threshold value was confirmed 
by visual comparison to the corresponding histological sections. 
 
Results and discussion 
- Morphological quantification of the scaffold characteristics 
When considering the volume of CaP in relation to the entire scaffold CopiOs™ 
contained significantly less than any other material (approximately 10 fold less than 
NuOss™ and Collagraft™; and 6 fold less than Bio-Oss® and Vitoss®), as shown in 
Figure 1A. Both NuOss™ and Collagraft™ contained approximately 20% CaP while 
Bio-Oss® and Vitoss® contained significantly lower levels at approximately 12%. 
Each material was distinctly different to NuOss when comparing the average grain 
size with Bio-Oss® containing on average the largest grains and CopiOs™ the 
smallest grains (Figure 1B). When analyzing the surface area of CaP within each 
material both Bio-Oss® and CopiOs™ contained significantly less than any other 
material, which was approximately 2 fold less than NuOss™ and Vitoss® (Figure 
1C). The specific surface area however was significantly higher for CopiOs™ and 
Vitoss® compared to the other materials (Figure 1D). 
- Quantification of the newly formed bone volume 
In the micro-CT images of the explants of NuOss™, Bio-Oss®, and Collagraft™ 
bone spicules could be clearly seen (white arrows; Figures 3A). Also, some explants 
of Vitoss® showed some bone spicules, however this was not seen in all explants. 
No bone formation was observed within the CopiOs™ material. Quantification of 
bone by micro-CT analysis (Figure 2C) revealed that NuOss™ implants contained 
the highest percentage of newly formed bone at 11.40% ± 1.48%, which was 
significantly higher than Bio-Oss® at 4.99% ± 0.82%, Collagraft™ at 3.04% ± 0.30%, 
and Vitoss® at 1.32% ± 0.14% (p<0.001). Bio-Oss® contained significantly more 
bone than Collagraft™ (p<0.001), however Bio-Oss® and Vitoss®, and Collagraft™ 
and Vitoss® were not statistically different (p>0.05). The volume of new formed bone 
was also calculated by histomorphometric analysis of the explants, which 
corresponded well (R² = 0.971) to the micro-CT data. 
 
Figure 1: High-resolution micro-CT was used to analyse the internal structure of the materials 
with respect to (A) volume fraction of the CaP grains (B) average grain size (C) surface area 
of CaP (D) specific surface area of the CaP grains. Statistical significance is compared to 
NuOss™ unless otherwise indicated. *: p < 0.05, **: p < 0.01, ***: p < 0.001. 
The available surface area is of importance for the bone forming capacity of the 
scaffold materials as it has previously been shown that CaP granules act as a local 
anchorage site for human periosteal cells [15], hence directly influence in vivo tissue 
formation. Additionally the bone forming classes of low (Vitoss® and Collagraft™), 
medium (Bio-Oss®) and high (NuOss™) can be discriminated mainly based on 
surface, average grain size and volume fraction of CaP. Each of these parameters 
has previously been shown to have an effect on bone formation. 
- Assessment of bone interconnectivity and the spatial localisation of the bone 
formed within the scaffold structure 
Figure 2B shows on a typical cross-sectional micro-CT image of a NuOss™ explant 
two interconnected bone spicules when analysed in three dimensions (indicated by 
the blue and yellow areas). For most of the explants of the different scaffold materials 
highly interconnected bone spicules were found. In order to locate the bone formed 
within the scaffold structure, the volume fraction of the CaP grains (Figure 3A) and 
the volume of newly formed bone (Figure 3B) were calculated within confined 
cylinders containing only the core, the middle and the edge region of the explant as 
indicated in figure 3D. The trendlines in both figure 3A and 3B show that there is a 
clear link between the volume fraction of the CaP grains and the volume of newly 
formed bone. 
 
Figure 2: (A) Typical high-resolution micro-CT images of NuOss™, Bio-Oss®, Collagraft™, 
CopiOs™ and Vitoss® implants seeded with one million cells eight weeks after implantation 
(isotropic voxel size = (4.5µm)³). Bone spicules are indicated with white arrows. The example 
shown in (B) displays 2 interconnected bone spicules when analysed in three dimensions 
(indicated by the blue and yellow areas). (C) Quantification of the newly formed bone volume 
in comparison to total implant volume allowed a bone volume fraction calculation to be carried 
out (n=4: duplicate implants in two mice). Statistical significance: *: p < 0.05, **: p < 0.01, ***: 
p < 0.001. Scale Bar = 1mm. 
 
 
Figure 3: For the different scaffold types (A) the micro-CT-based volume fraction of the newly 
formed bone distributed over the core, middle and edge of the scaffold and (B) the micro-CT 
based volume fraction of the CaP particles distributed over the core, middle and edge of the 
scaffold, showing the same distribution as the volume fraction of newly formed bone. (C) 
Typical cross-sectional micro-CT images of a NuOss
TM
 explant, indicating how the core, 
middle and edge region are defined (scale bar = 1 mm). 
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Conclusion 
After validation, micro-CT image analysis enables an in-depth 3D and quantitative 
characterization of the material properties of CaP scaffolds and their in vivo bone 
formation capacity in combination with hPDCs. The results from the micro-CT image 
analysis have been used to link specific scaffold properties to the scaffold’s bone 
forming capacity, which can provide a rationale for initial scaffold selection based on 
the materials characteristics. 
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